Filing Details
- Accession Number:
- 0001104659-20-132978
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-07 21:30:20
- Reporting Period:
- 2020-12-03
- Accepted Time:
- 2020-12-07 21:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1393434 | Ocular Therapeutix Inc | OCUL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1228459 | Bruce Peacock | C/O Ocular Therapeutix, Inc. 24 Crosby Drive Bedford MA 01730 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-03 | 18,000 | $3.90 | 18,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-03 | 7,000 | $8.14 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-03 | 25,000 | $0.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-03 | 18,000 | $0.00 | 18,000 | $3.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-12-03 | 7,000 | $0.00 | 7,000 | $8.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-06-10 | No | 4 | M | Direct | |
| 11,000 | 2028-06-13 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.36 to $18.45, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- This option was granted on June 11, 2019 and fully vested on June 11, 2020.
- This option was granted on June 14, 2018 and fully vested on June 14, 2019.
Billionaire Hedge Funds
